PRONOVA BIOPHARMA ASA - BASF AS achieves acceptance of more than 97 % of shares
In the conditional voluntary offer (the "Voluntary
Offer") for all of the outstanding shares in Pronova
BioPharma ASA ("Pronova"), BASF AS announces that
following the expiration of the offer period on 18
January 2013 at 16:30 CET received acceptances under
the Voluntary Offer for 293'975'655 shares
representing approximately 97.72 percent of the
issued shares and votes in Pronova.
As announced on 09 January 2013 all regulatory
approvals required for completion of the Voluntary
Offer have been obtained.BASF intends to complete the
Offer subject to the satisfaction or waiver of the
remaining conditions to the Offer as set forth in the
Offer Document, Section 4.7, as soon as possible.